July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Relationship between plasma aldosterone concentration and retinal ganglion cell death
Author Affiliations & Notes
  • Yukari Takasago
    Kagawa Univ, Kitagun, Kagawa, Japan
  • Kazuyuki Hirooka
    Kagawa Univ, Kitagun, Kagawa, Japan
  • Aoi Ono
    Kagawa Univ, Kitagun, Kagawa, Japan
  • Mamoru Kobayashi
    Kagawa Univ, Kitagun, Kagawa, Japan
  • Yuki Nakano
    Kagawa Univ, Kitagun, Kagawa, Japan
  • Footnotes
    Commercial Relationships   Yukari Takasago, None; Kazuyuki Hirooka, None; Aoi Ono, None; Mamoru Kobayashi, None; Yuki Nakano, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 5510. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yukari Takasago, Kazuyuki Hirooka, Aoi Ono, Mamoru Kobayashi, Yuki Nakano; Relationship between plasma aldosterone concentration and retinal ganglion cell death. Invest. Ophthalmol. Vis. Sci. 2018;59(9):5510.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We recently reported that the retinal ganglion cell (RGC) loss associated with the thinning of the retinal nerve fiber layer without elevated intraocular pressure that occurs after the systemic administration of aldosterone. The purpose of this study was to investigate the relationship between plasma aldosterone concentration and the number of RGCs after systemic administration of aldosterone.

Methods : 40, 80 or 160 µg/kg/day aldosterone or vehicle was administered via osmotic minipump which was implanted subcutaneously into the mid-scapular region. The plasma aldosterone concentration was measured using enzyme immunoassay kits at 2 weeks after systemic administration of aldosterone or vehicle. At 5 weeks after systemic administration of aldosterone or vehicle, Fast Blue was injected bilaterally into the superior colliculi of rats. The number of RGCs was measured at 6 weeks after systemic administration of aldosterone or vehicle. Data was analyzed using Dunnett’s multiple comparison test.

Results : Plasma aldosterone concentration was 212 ± 18 pg/ml, 366 ± 94 pg/ml, 478 ± 75 pg/ml and 1790 ± 473 pg/ml in the vehicle or 40, 80, or 160 μg/kg/day aldosterone-treated rats, respectively. Plasma aldosterone concentration was significantly increased in the 160 μg/kg/day aldosterone-treated rats (P < 0.001). The number of RGCs was 2688 ± 407 cells/mm2, 2240 ± 357 cells/mm2, 2086 ± 338 cells/mm2, 137 ± 110 cells/mm2 in the vehicle or 40, 80, or 160 μg/kg/day aldosterone-treated rats, respectively. RGCs were significantly decreased in the 80, 160 µg/kg/day aldosterone-treated rats (P < 0.001). The number of RGCs was significantly correlated with plasma aldosterone concentration, with correlation coefficient of -0.911.

Conclusions : There was a negatively correlated between plasma aldosterone concentration and the number of RGCs.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×